Protecting confidentiality during an ABA practice sale

Protecting confidentiality during an ABA practice sale
QUICK ANSWER A confidential ABA practice sale uses staged disclosure, verified recipients, reviewed documents and controlled access. An NDA supports commercial confidentiality but does not resolve patient-privacy permissions. Establish separate review for protected health information, personnel data and competitive information, and prepare a response plan before outreach begins.

Decide how information will move before it starts moving

A prospective buyer asks for a staffing roster. A financial adviser requests claims detail. Someone suggests a clinic visit. Each request may have a legitimate purpose, but together they can reveal the transaction, expose private information or give a competitor more detail than it needs at that stage.

A confidential ABA practice sale needs a disclosure plan covering people, documents, conversations and visits. Decide what can be shared, with whom, for which purpose and after which review. Keep a record of the decision. This article focuses on information control; the broader guide to selling an ABA therapy practice explains the full transaction process. Selling an ABA therapy practice: the owner process

No process can promise absolute secrecy. The practical aim is to reduce unnecessary exposure, meet applicable obligations and respond promptly when something goes wrong. Commercial confidentiality, patient privacy and employee privacy need related but distinct attention.

Appoint a disclosure lead and separate the information categories

Choose one person to coordinate incoming requests and approved responses, with a named backup. That person need not make every legal or clinical decision. They should know who must review financial reports, personnel information, patient-related material and commercially sensitive contracts before release.

Use a simple request register. Record the requester, purpose, requested detail, proposed recipient group, review decision and version released. If the same question arrives from several advisers, provide a controlled answer instead of allowing several staff members to send different files. Record refusals and proposed alternatives as well as approvals.

Separate ordinary business summaries from restricted material. Revenue by broad service category raises different issues from patient-level claims or personnel medical information. The first useful response may be a summary that answers the buyer’s question without opening the more sensitive file. Classification should happen before uploading, not after access has been granted.

Check whether the anonymous introduction is identifiable

A teaser can disclose your identity without naming the practice. A distinctive location pattern, exact founding year, unusual service mix and founder biography may narrow the field quickly for someone who knows the local market. Review the combination of details through the eyes of that reader.

Decide which facts a buyer needs to establish initial interest. Broader geography or a carefully described operating profile may be enough at that stage. Avoid making the business sound materially different in pursuit of anonymity; you still need an accurate introduction. Have someone outside the drafting team test whether the description is both useful and unnecessarily revealing.

Inspect document properties, filenames, logos, chart labels and linked material too. A neutral project name on the cover does little if the filename contains the practice name. Keep the approved outreach list and introduction version together so you know who received what.

Use an NDA as one control within the process

Have counsel review confidentiality terms for the actual transaction. Questions include who may receive information, permitted use, responsibility for representatives, restrictions on contact, handling of compelled disclosures and what happens when discussions end. The appropriate language depends on the parties and circumstances.

Operationalize the agreement after signature. Verify the recipient organization and authorized advisers. Give access to named people with a business reason to receive it, and route requests for additional recipients back through the agreed process. A signature does not tell your staff which folder a particular adviser should see.

Patient information needs its own legal analysis. The HIPAA health care operations definition includes specified sales, transfers, mergers and related diligence involving another covered entity or an entity that will become one after the activity. That definition is conditional and does not settle every proposed disclosure. Have privacy counsel assess the transaction and data flow. 45 CFR 164.501 health care operations definition 

Answer diligence questions with the least sensitive workable evidence

Begin with the question the buyer is trying to answer. To examine denial trends, it may initially need totals by period and category rather than patient records. To assess staffing, it may need roles, tenure and vacancies before named personnel files. Ask whether the proposed detail materially improves that stage of evaluation.

Where HIPAA’s minimum necessary standard applies, covered entities must take reasonable steps to limit the information used or disclosed to the intended purpose. HHS also identifies exceptions, so apply the standard through a transaction-specific review rather than a blanket slogan. HHS minimum necessary guidance 

De-identification requires more than removing a name column. HHS describes Safe Harbor and Expert Determination methods, each with requirements. Dates, free text and other characteristics can retain identification risk. Have a qualified person assess the actual dataset and document the method before describing it as de-identified. HHS methods for de-identifying protected health information 

Do not label a prospective buyer a business associate merely to facilitate sharing. HHS defines that role by the activities or services performed, with applicable written arrangements. Counsel should assess advisers and vendors based on their actual functions and whether they handle protected information. A BAA is not a substitute for evaluating the underlying relationship and disclosure. HHS business associate guidance 

Give competing buyers an appropriately restricted review route

A local competitor may have a legitimate interest in the practice and also compete for clinicians, patients or payer relationships. Exact payer prices, individual compensation, expansion plans and future strategy warrant particular care. Decide with antitrust counsel how relevant evidence can be reviewed without unnecessarily exposing competitive detail.

The FTC warns that information sharing during merger discussions can create antitrust concerns, and the parties remain independent businesses before closing. Its guidance discusses controls such as appropriately structured clean teams and restricted access. The right approach depends on the information and transaction; calling a folder a clean room is not enough. FTC pre-merger information-sharing guidance 

If a clean team is used, define membership, permitted access, output review and what can be reported to commercial decision-makers. Avoid giving detailed restricted information to people who negotiate competing prices or manage competitive strategy without appropriate advice. Keep a record of the approved arrangement and revisit it when the recipient group changes.

Configure the data room for actual users and documents

Use named accounts, appropriate authentication and folder permissions that reflect the disclosure plan. Test what each recipient group can see before inviting it. Assign one person to maintain access when advisers join or leave, and avoid shared credentials that make accountability difficult.

Consider view-only access, download restrictions, watermarking and activity logs where useful and supported. These features can help manage exposure, but none guarantees that information cannot be copied. The most important decision remains whether the recipient should receive the information in the first place.

Review files before release. Check hidden spreadsheet tabs, comments, tracked changes, embedded objects and unredacted appendices. A PDF made from a workbook may omit the evidence a buyer needs or reveal more than the preparer intended. Confirm the released version answers the approved question and contains only the authorized material. What shapes the timeline of an ABA practice sale

Plan conversations and visits as carefully as uploads

Brief everyone who will speak to prospective buyers. Identify the subjects they can discuss, the questions they should route elsewhere and the transaction status they may describe. Use an agreed contact path for employees, families, referral sources and payers instead of allowing direct outreach to develop informally.

For site visits, consider who will attend, where discussions will occur and what visitors may see. Patient schedules, whiteboards, unattended screens and casual introductions can reveal sensitive information. Coordinate the visit with clinical and privacy leaders so care and confidentiality remain protected. Discretion should never require misleading families or ignoring applicable notice obligations.

Prepare accurate responses to staff questions and rumors. Managers should know which facts are confirmed and where to send concerns. Do not promise that a transaction is impossible if discussions are underway. Also do not disclose an unapproved buyer identity or prospective employment change simply to fill an uncomfortable silence.

Prepare for a leak or a buyer leaving the process

Agree in advance whom staff should contact if information goes to the wrong recipient or a rumor becomes public. Preserve the relevant record and involve the privacy, security and legal professionals appropriate to the incident. They should determine containment, investigation and any required notifications. Avoid assuming that recalling an email resolves the matter.

When a buyer withdraws, remove access promptly under the agreed process and address retained materials according to the contracts and applicable requirements. Identify adviser accounts as well as the buyer’s own users. Ask counsel how retention exceptions, legal holds and certifications should be handled rather than deleting everything indiscriminately.

At closing, revisit the permissions map. Transaction access does not automatically become unrestricted operational access. Confirm who needs each system, what records must remain available and who owns unresolved disclosure issues. Keep the decision trail so the handover can be checked later.

Frequently asked questions

Can I keep an ABA sale completely confidential?

Absolute secrecy cannot be guaranteed. A carefully limited outreach process, reviewed materials, controlled access and planned communications can reduce unnecessary exposure. Identify the situations in which disclosure or notice may be required and prepare for rumors or misdirected information rather than assuming the transaction will remain unknown.

Does an NDA let me share patient records with a buyer?

An NDA alone does not establish permission to disclose protected health information. Have privacy counsel review the proposed transaction, recipient, purpose, information and applicable requirements before release. Start with less sensitive evidence when it can answer the diligence question, and document the approved disclosure route. 45 CFR 164.501 health care operations definition 

Is deleting patient names enough to de-identify a spreadsheet?

No. Other fields and combinations of information may identify people. HHS describes specific Safe Harbor and Expert Determination methods. The appropriate method and resulting dataset need qualified review; removing obvious identifiers without that assessment should not be described as verified de-identification. HHS methods for de-identifying protected health information 

Should every buyer adviser receive the same data room access?

Access should reflect the purpose and approved role. A financial reviewer, transaction lawyer and operating executive may need different material. Check additional recipients before granting access, keep a record of the released files and review permissions when the team changes or discussions end.

What changes when the buyer is a competitor?

Competitively sensitive information needs particular review. Ask antitrust counsel whether aggregation, delayed disclosure, restricted advisers or a properly structured clean team is appropriate. The parties must continue to operate independently before closing, and a signed confidentiality agreement does not eliminate information-sharing concerns. FTC pre-merger information-sharing guidance 

What should I do if a confidential document is misdirected?

Promptly use the practice’s incident-response route, preserve the facts and involve the appropriate privacy, security and legal professionals. They can assess containment and any notification duties. Record the recipient, material, timing and actions taken. Do not assume a deletion request or email recall has resolved the incident.

Start buyer outreach with the confidentiality plan ready

For the sequence around these disclosures, read Selling an ABA therapy practice: the owner process. The practical scheduling questions are covered in What shapes the timeline of an ABA practice sale.

Before approaching buyers, assemble an approved introduction, recipient list, request register and disclosure responsibilities. Resolve the route for patient-related and competitively sensitive evidence before the first detailed request arrives. This can make legitimate diligence easier to support without improvising permissions under pressure.

Olympic M&A’s behavioral health advisory team is a starting point for discussing a confidential ABA sale process. Bring your concerns about market visibility, staff communication and sensitive information, and involve privacy and transaction counsel where needed. Visit the behavioral health advisory page to discuss the process you want to run. Olympic M&A behavioral health advisory 

Facebook
Twitter
LinkedIn
Pinterest